XML 449 R393.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule I Condensed Financial Statements (Parent Company Only) - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Condensed Financial Statements, Captions [Line Items]      
Cash flows from operating activities $ 7,132 $ 9,359 $ 8,692
Cash flows from investing activities:      
Purchases of marketable securities (314) (574) (297)
Proceeds from sales of marketable securities 2,520 2,464 273
Other, net 17 (28) (94)
Net cash flows from investing activities (5,899) (7,750) (5,763)
Cash flows from financing activities:      
Preferred stock redemptions (850) (800) (2,100)
Preferred dividends (38) (50) (132)
Common stock purchases 0 (870) 0
Net proceeds from (repayments of) short-term debt 3,024 (867) (276)
Other, net (54) (274) (70)
Net cash flows from financing activities (1,250) (1,006) (3,131)
Net change in cash and cash equivalents and restricted cash and cash equivalents (6) 573 (201)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 1,817 1,244 1,445
Cash and cash equivalents and restricted cash and cash equivalents at end of period 1,811 1,817 1,244
MidAmerican Funding LLC      
Condensed Financial Statements, Captions [Line Items]      
Cash flows from operating activities (12) (12) (12)
Cash flows from investing activities:      
Proceeds from dividends received 1,025 69 0
Net cash flows from investing activities 1,025 69 0
Cash flows from financing activities:      
Distributions (1,025) (69) 0
Notes payable to affiliate, net 12 12 12
Net cash flows from financing activities (1,013) (57) 12
Net change in cash and cash equivalents and restricted cash and cash equivalents 0 0 0
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents and restricted cash and cash equivalents at end of period 0 0 0
Parent Company      
Condensed Financial Statements, Captions [Line Items]      
Cash flows from operating activities 5,824 1,252 1,819
Cash flows from investing activities:      
Investments in subsidiaries (4,995) (1,085) (1,206)
Purchases of marketable securities (39) (20) (29)
Proceeds from sales of marketable securities 35 11 28
Proceeds from other investments 0 0 1,290
Notes receivable from affiliate, net (571) 390 200
Other, net (18) (44) (20)
Net cash flows from investing activities (5,588) (748) 263
Cash flows from financing activities:      
Preferred stock redemptions (850) (800) (2,100)
Preferred dividends (38) (50) (132)
Common stock purchases 0 (870) 0
Proceeds from BHE senior debt 0 986 0
Repayments of BHE senior debt (900) 0 (450)
Net proceeds from (repayments of) short-term debt 1,690 245 0
Other, net (4) (1) (5)
Net cash flows from financing activities (102) (490) (2,687)
Net change in cash and cash equivalents and restricted cash and cash equivalents 134 14 (605)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 32 18 623
Cash and cash equivalents and restricted cash and cash equivalents at end of period $ 166 $ 32 $ 18